In a report released on October 4, Carter Gould from Barclays maintained a Buy rating on Merck & Company (MRK – Research Report), ...

The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...

We recently compiled a list of 10 Most Promising Long-Term Stocks According to Hedge Funds. In this article, we will look at ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday. Terence Flynn has given ...

We recently compiled a list of the 7 Blue Chip Stocks with Low PE Ratios. In this article, we are going to take a look at ...

Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a major player in healthcare. Specializing in ...

Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...

(RTTNews) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the RNA-particle technology vaccine for the treatment ...

RAHWAY, N.J. - Merck Animal Health, a division of Merck & Co., Inc. (NYSE:MRK), has announced the release of a new vaccine, NOBIVAC NXT FeLV, to protect cats against feline leukemia virus (FeLV).